Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash & Equivalents (2016 - 2025)

Bio-Techne has reported Cash & Equivalents over the past 17 years, most recently at $172.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $172.9 million for Q4 2025, down 2.63% from a year ago — trailing twelve months through Dec 2025 was $172.9 million (down 2.63% YoY), and the annual figure for FY2025 was $162.2 million, up 6.85%.
  • Cash & Equivalents for Q4 2025 was $172.9 million at Bio-Techne, up from $145.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for TECH hit a ceiling of $211.8 million in Q4 2021 and a floor of $127.3 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $165.0 million (2022), compared with a mean of $166.0 million.
  • Biggest five-year swings in Cash & Equivalents: soared 77.49% in 2021 and later fell 22.7% in 2025.
  • Bio-Techne's Cash & Equivalents stood at $211.8 million in 2021, then fell by 22.26% to $164.7 million in 2022, then fell by 20.98% to $130.1 million in 2023, then soared by 36.44% to $177.5 million in 2024, then decreased by 2.63% to $172.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $172.9 million (Q4 2025), $145.0 million (Q3 2025), and $162.2 million (Q2 2025) per Business Quant data.